These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


263 related items for PubMed ID: 19560809

  • 1. Treatment of rheumatoid arthritis: we are getting there.
    Yazici Y.
    Lancet; 2009 Jul 18; 374(9685):178-80. PubMed ID: 19560809
    [No Abstract] [Full Text] [Related]

  • 2. New drugs for rheumatoid arthritis.
    Messori A, Santarlasci B, Vaiani M.
    N Engl J Med; 2004 Aug 26; 351(9):937-8. PubMed ID: 15329436
    [No Abstract] [Full Text] [Related]

  • 3. Disease-modifying antirheumatic drugs: enhancing efficacy by combination.
    Schnabel A.
    Lancet; 2004 Feb 28; 363(9410):670-1. PubMed ID: 15001319
    [No Abstract] [Full Text] [Related]

  • 4. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
    Garcia-Porrua C, Gonzalez-Gay MA, Quevedo V.
    J Rheumatol; 2006 Feb 28; 33(2):433; author reply 433-4. PubMed ID: 16465676
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adalimumab for rheumatoid arthritis?
    Ebell M, Kripke C.
    Am Fam Physician; 2006 Feb 01; 73(3):435-6. PubMed ID: 16479667
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Biologic therapy with anti-TNFα in rheumathoid arthritis].
    Ferraccioli G.
    Reumatismo; 2005 Feb 01; 57(4 Suppl):17-21. PubMed ID: 16385351
    [Abstract] [Full Text] [Related]

  • 9. Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy.
    Boers M, COBRA Study Group. Combinatietherapie Bij Reumatoide Artritis.
    Arthritis Rheum; 2001 Nov 01; 44(11):2703-4. PubMed ID: 11710727
    [No Abstract] [Full Text] [Related]

  • 10. Infliximab treatment of rheumatoid arthritis.
    Maini SR.
    Rheum Dis Clin North Am; 2004 May 01; 30(2):329-47, vii. PubMed ID: 15172044
    [Abstract] [Full Text] [Related]

  • 11. Rheumatoid arthritis.
    Burchini G, Orsi C.
    N Engl J Med; 2004 Sep 23; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.
    Richez C, Blanco P, Gin H, Schaeverbeke T.
    Clin Exp Rheumatol; 2006 Sep 23; 24(5):607. PubMed ID: 17181936
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis.
    Wakefield RJ, Freeston JE, Hensor EM, Bryer D, Quinn MA, Emery P.
    Arthritis Rheum; 2007 Dec 15; 57(8):1564-7. PubMed ID: 18050231
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.